VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
暂无分享,去创建一个
Marina Ziche | Lucia Morbidelli | Yan Qiu | Steven J. Harper | Jacqueline D. Shields | D. Gillatt | S. Harper | D. Bates | R. Foster | L. Morbidelli | M. Ziche | Y. Qiu | J. Woolard | R. Mushens | H. Bevan | R. Pritchard-Jones | Tai-Gen Cui | Jeanette Woolard | Wen-Ying Wang | Heather S. Bevan | Rowan O. Pritchard-Jones | Marto Sugiono | Elizabeth Waine | Rachel Perrin | Rebecca Foster | Jonathon Digby-Bell | Cheryl E. Whittles | Rosey E. Mushens | David A. Gillatt | David O. Bates | C. Whittles | T. Cui | M. Sugiono | R. Perrin | Wen-ying Wang | J. Shields | E. Waine | J. Digby-Bell | Rachel M. Perrin
[1] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[2] S. Harper,et al. An Adenovirus‐Mediated Gene‐Transfer Model of Angiogenesis in Rat Mesentery , 2004, Microcirculation.
[3] D. Gillatt,et al. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. , 2004, American journal of physiology. Renal physiology.
[4] G. Neufeld,et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants , 1996, Cancer and Metastasis Reviews.
[5] D. Mukhopadhyay,et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. , 2003, The Journal of clinical investigation.
[6] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[7] Christoph Dehio,et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 , 2003, Nature Medicine.
[8] Jianzhong Huang,et al. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Gillatt,et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. , 2003, American journal of physiology. Renal physiology.
[10] John I. Loewenstein,et al. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. , 2003, Ophthalmology.
[11] P. Carmeliet,et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.
[12] Napoleone Ferrara,et al. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. , 2002, Seminars in oncology.
[13] R. Bachelder,et al. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. , 2002, Cancer research.
[14] D. Bates,et al. ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor‐Receptor‐2 Tyrosine Kinase Activity , 2002, Microcirculation.
[15] S. Harper,et al. Regulation of vascular permeability by vascular endothelial growth factors. , 2002, Vascular pharmacology.
[16] Holger Gerhardt,et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.
[17] P. Quaglino,et al. VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course , 2002, Melanoma research.
[18] D. Gillatt,et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. , 2002, Cancer research.
[19] N. Ferrara,et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism , 2002, Nature.
[20] D. Bates,et al. Regulation of microvascular permeability by vascular endothelial growth factors * , 2002, Journal of anatomy.
[21] M. Perrot-Applanat,et al. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. O'hare,et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.
[23] P. Schimmel,et al. A fragment of human TrpRS as a potent antagonist of ocular angiogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] L. Créancier,et al. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. , 2001, Molecular endocrinology.
[25] A. Verin,et al. Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[26] A. D. de Vos,et al. Vascular Endothelial Cell Growth Factor-Driven Endothelial Tube Formation Is Mediated by Vascular Endothelial Cell Growth Factor Receptor-2, a Kinase Insert Domain-Containing Receptor , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[27] L. Shaw,et al. Advances in Brief Vascular Endothelial Growth Factor Is an Autocrine Survival Factor for Neuropilin-expressing Breast Carcinoma Cells 1 , 2001 .
[28] N. Ferrara. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. , 2001, American journal of physiology. Cell physiology.
[29] D. Bates,et al. Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways , 2001, The Journal of physiology.
[30] M. Dake,et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.
[31] Till Acker,et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.
[32] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[33] R Bicknell,et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo , 2000, British Journal of Cancer.
[34] L. Mayo,et al. Utilization of Distinct Signaling Pathways by Receptors for Vascular Endothelial Cell Growth Factor and Other Mitogens in the Induction of Endothelial Cell Proliferation* , 2000, The Journal of Biological Chemistry.
[35] D. Charnock-Jones,et al. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. , 1999, Molecular endocrinology.
[36] Wei Li,et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. , 1999, Experimental cell research.
[37] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] Y. Fukushima,et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. , 1999, European journal of cancer.
[39] T. Pihlajaniemi,et al. Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[40] R Bicknell,et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.
[41] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[42] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[43] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[44] Hung V. Nguyen,et al. The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.
[45] S. Mori,et al. Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. , 1995, The Journal of clinical endocrinology and metabolism.
[46] H. Dvorak,et al. Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. , 1995, The Journal of urology.
[47] L. Zardi,et al. The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesis , 1994, International journal of cancer.
[48] E. Kardami,et al. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. , 1994, Journal of molecular and cellular cardiology.
[49] E. Manseau,et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. , 1993, The American journal of pathology.
[50] P. Chomczyński,et al. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. , 1993, BioTechniques.
[51] E. Oldfield,et al. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. , 1993, The American journal of physiology.
[52] E. Manseau,et al. Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.
[53] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[54] J. Winer,et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. , 1991, Molecular endocrinology.
[55] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[56] K. Norrby,et al. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.